Offspring birthweight is not associated with paternal insulin resistance

Area of Science:

• Endocrinology
• Metabolic Health
• Perinatal Research

Background:

• Low birthweight is linked to later-life insulin resistance, diabetes, hypertension, and vascular disease.
• The foetal insulin hypothesis suggests a shared genetic basis for beta-cell dysfunction, low birthweight, and type 2 diabetes.
• The precise mechanism linking low birthweight and insulin resistance remains unclear.

Purpose of the Study:

• To investigate the association between paternal insulin resistance and offspring birthweight.
• To test the prediction of the foetal insulin hypothesis regarding paternal factors and fetal growth.
• To explore potential genetic predispositions linking parental metabolic health to offspring birth outcomes.

Main Methods:

• Utilized data from the Exeter Family Study of Childhood Health (EFSOCH), a UK-based prospective study.
• Analyzed homeostasis model assessment (HOMA) for paternal insulin resistance in 986 families.
• Controlled for paternal BMI and other confounders in singleton, non-diabetic pregnancies.

Main Results:

• No significant correlation was found between log paternal insulin resistance and offspring birthweight (r=0, p=0.91).
• Paternal HDL cholesterol and triglyceride levels also showed no significant association with birthweight.
• Multiple linear regression confirmed paternal insulin resistance is not an independent predictor of offspring birthweight.

Conclusions:

• The study's findings do not support the foetal insulin hypothesis.
• Results suggest that paternal insulin resistance is not a determinant of offspring birthweight in this population.
• Further research is needed to elucidate the mechanisms underlying the association between low birthweight and later-life insulin resistance.